-transparent.png){kind=logo}
1) Lipophilic ganglioside GD1a (IV3NeuAc, II3NeuAc-GgOse4-Cer) is taken up by the cell membranes and hydrolyzed faster by membrane-bound neuraminidase than are water soluble substrates of the enzyme. 2) The enzymic breakdown of ganglioside GD1a is enhanced by general anesthetics whereas the degradation of the hydrophilic substrate sialyllactitol is reduced by these same agents. 3) General anesthetics lower the microviscosity of membranes as indicated by studies of fluorescence depolarisation with the indicator 1,6-diphenylhexatrien. Decreased microviscosity can result in a higher lateral diffusion of ganglioside GD1a, increasing its interaction with membrane-bound neuraminidase. 4) In vitro studies indicate that the activity of membrane-bound neuraminidase on gangliosides of brain membranes is regulated by the viscosity of these membranes and their monosialoganglioside content.
K Sandhoff, and
B Pallmann, and
H Wiegandt, and
W Ziegler
June 1974,
Biochimica et biophysica acta,
K Sandhoff, and
B Pallmann, and
H Wiegandt, and
W Ziegler
April 1983,
The Biochemical journal,
K Sandhoff, and
B Pallmann, and
H Wiegandt, and
W Ziegler
September 1981,
Life sciences,
K Sandhoff, and
B Pallmann, and
H Wiegandt, and
W Ziegler
June 1974,
Biochimica et biophysica acta,
K Sandhoff, and
B Pallmann, and
H Wiegandt, and
W Ziegler
November 2002,
Biological chemistry,
K Sandhoff, and
B Pallmann, and
H Wiegandt, and
W Ziegler
January 1979,
Life sciences,
K Sandhoff, and
B Pallmann, and
H Wiegandt, and
W Ziegler
March 1976,
FEBS letters,
K Sandhoff, and
B Pallmann, and
H Wiegandt, and
W Ziegler
November 1960,
Biochemical and biophysical research communications,
K Sandhoff, and
B Pallmann, and
H Wiegandt, and
W Ziegler
October 1974,
Experientia,
K Sandhoff, and
B Pallmann, and
H Wiegandt, and
W Ziegler
May 1982,
Biochemical pharmacology,
